Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Idexx Laboratories, Inc shares valued at $263,813 were sold by Erickson Michael G on Aug 12 ’25. At $649.96 per share, Erickson Michael G sold 406 shares. The insider’s holdings dropped to 11,287 shares worth approximately $7.38 million following the completion of this transaction.
Also, Hunt Nimrata sold 1,200 shares, netting a total of over 787,840 in proceeds. Following the sale of shares at $656.53 each, the insider now holds 16,807 shares.
Before that, MICHAEL G ERICKSON had added 407 shares to its account. In a trade valued at $264,534, the Officer bought Idexx Laboratories, Inc shares for $649.96 each.
As published in a research note from BTIG Research on August 05, 2025, Idexx Laboratories, Inc [IDXX] has been retained to a Buy and the price target has been revised to $785. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in early July. As of December 02, 2024, Leerink Partners has initiated its “an Outperform” rating for IDXX. Earlier on July 25, 2024, BTIG Research initiated its rating. Their recommendation was “a Buy” for IDXX stock.
Analyzing IDXX Stock Performance
On last trading session, Idexx Laboratories, Inc [NASDAQ: IDXX] plunged -1.50% to $653.95. The stock’s lowest price that day was $648.17, but it reached a high of $664.11 in the same session. During the last five days, there has been a surge of approximately 0.60%. Over the course of the year, Idexx Laboratories, Inc shares have jumped approximately 36.26%. Shares of the company reached a 52-week high of $688.12 on 08/04/25 and a 52-week low of $356.14 on 04/09/25.
Support And Resistance Levels for Idexx Laboratories, Inc (IDXX)
According to the 24-hour chart, there is a support level at 646.71, which, if violated, would cause prices to drop to 639.47. In the upper region, resistance lies at 662.65. The next price resistance is at 671.35. RSI (Relative Strength Index) is 64.65 on the 14-day chart, showing neutral technical sentiment.
Is Idexx Laboratories, Inc subject to short interest?
Stocks of Idexx Laboratories, Inc saw a sharp steep in short interest on 2025-07-31 dropping by 63993.0 shares to 2.48 million. Data from Yahoo Finance shows that the short interest on 2025-06-30 was 2.55 million shares. A decline of -2.58% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 4.68 of the overall float, the days-to-cover ratio (short ratio) decline to 4.68.
Which companies own the most shares of Idexx Laboratories, Inc (IDXX)?
In terms of Idexx Laboratories, Inc share price expectations, FactSet research, analysts set an average price target of 722 in the next 12 months, up nearly 8.75% from the previous closing price of $663.92. Analysts anticipate Idexx Laboratories, Inc stock to reach 785 by 2025, with the lowest price target being 640. In spite of this, 6 analysts ranked Idexx Laboratories, Inc stock as Buy at the end of 2025. On January 30, 2024, Piper Sandler assigned a price target of “a Neutral” to the stock and downgraded coverage with a $525.
